Earlier this week, the Singapore-headquartered solar panel maker confirmed it filed a lawsuit in the Eastern District of Texas against Hanwha Q Cells, following its own investigation into several ...
Altered phosphorylation endows LB-100-treated colorectal adenocarcinoma cells with differential splicing patterns. In PP2A-inhibited cells, over 1000 events of exon skipping and intron retention ...
SINGAPORE - Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN), known for its solar technology innovations, has launched a patent infringement lawsuit against Hanwha Q CELLS in the Eastern ... in advancing ...
SINGAPORE - Maxeon Solar Technologies, Ltd. (NASDAQ :MAXN), known for its solar technology innovations, has launched a patent infringement lawsuit against Hanwha Q CELLS in the Eastern ... in ...
SINGAPORE, April 22, 2024 /PRNewswire/ -- Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN), a global leader in solar innovation and channels, today announced that it has initiated a patent ...
Maxeon's leadership in solar technology is the result of nearly 40 years of research of development and over half a billion dollars of investment since 2007, leading to major advances in solar cell ...
Maxeon's leadership in solar technology is the result of nearly 40 years of research of development and over half a billion dollars of investment since 2007, leading to major advances in solar cell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results